Trial Profile
Double-blind, placebo controlled randomized study of co-administering testosterone with PDE5 [phosphodiesterase V] inhibitors in patients non-responders to PDE5 inhibitors alone
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 02 Aug 2022
Price :
$35
*
At a glance
- Drugs Testosterone (Primary) ; Tadalafil
- Indications Erectile dysfunction
- Focus Therapeutic Use
- Acronyms TADTEST
- 27 Dec 2012 New source identified and integrated (German Clinical Trials Register; DRKS00004081).
- 08 May 2009 Results presented at the 104th Annual Meeting of the American Urological Association (AUA), 2009.
- 24 Aug 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.